Parabolic Biologicals SRL
Parabolic Biologicals reported total assets of 132,669 € at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Jul 2026).
The score of Parabolic Biologicals shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +74 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Parabolic Biologicals's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Jul 2026
- Year ended 31 Dec 2024filed on 13 Mar 2025
- Year ended 31 Dec 2023filed on 27 May 2024
- Year ended 31 Dec 2022filed on 15 Jun 2023
- Year ended 31 Dec 2021filed on 07 Jul 2022
Parabolic Biologicals's financial analysis
- Solvency-85.6%sector median: 34.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Parabolic Biologicals
Parabolic Biologicals's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0458.736.853
- VAT number
- BE0458736853
- Peppol
- Registered · 0208:0458736853 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 05 Sep 1996
- Registered office
- 5101 Namur
- Latest accounts
- 2025 · filed on 27 Jul 2026
- Activity
- Manufacture of other pharmaceutical products (NACE 21209)
Parabolic Biologicals (SRL) has been based in Namur since 1996, active in: manufacture of other pharmaceutical products. For 2025, it reports a net profit of 89,315 € and equity of −113,586 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Parabolic Biologicals
Companies in the same business, of comparable size and area, outside its group.
- Prieka Manufacture of pharmaceutical preparations Etterbeek · balance sheet 440,325 €
- Thameus Manufacture of pharmaceutical preparations Liège · balance sheet 502,659 €
- Belgica Manufacture of pharmaceutical preparations Ghent · balance sheet 567,720 €
- BelCoPhar Manufacture of pharmaceutical preparations Kalmthout · balance sheet 224,468 €
- European Laboratory Supplies Manufacture of pharmaceutical preparations Soignies · balance sheet 257,481 €
- Mountvector Bio Manufacture of pharmaceutical preparations Ottignies-Louvain-la-Neuve · balance sheet 180,416 €
- L - Pharma Manufacture of pharmaceutical preparations Turnhout · balance sheet 10 €
- RTLC Manufacture of pharmaceutical preparations Brussels · balance sheet 107,167 €
Frequently asked questions about Parabolic Biologicals
What is the revenue of Parabolic Biologicals?
Parabolic Biologicals files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Parabolic Biologicals?
In Belgium, the VAT number is the company number prefixed with BE: BE0458736853 for Parabolic Biologicals, if the company is VAT-registered. Its company number (CBE) is 0458.736.853.
Where is the registered office of Parabolic Biologicals?
According to the CBE register, the registered office of Parabolic Biologicals is in 5101 Namur.
What is the equity of Parabolic Biologicals?
At the close of the 2025 financial year, the equity of Parabolic Biologicals amounts to -113,586 €, a solvency of -85.6% of total assets.
Who manages Parabolic Biologicals?
The register lists 1 active mandates at Parabolic Biologicals. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Parabolic Biologicals
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →